Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
New words:
accrued, amended, Amendment, annum, April, August, Board, calendar, China, Chinese, conversion, convert, convertible, demand, feature, grant, Group, holder, Incorporation, increase, increased, July, made, order, paid, payable, price, product, public, quoted, rate, referred, reflect, reincorporation, restated, retroactively, reverse, split, time
Removed:
activity, compared, decrease, decreased, Edgeline, low
Filing tables
Filing exhibits
BECC similar filings
Filing view
External links
EXHIBIT 31.1
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized
ONCOLIN THERAPEUTICS, INC.
By: /s/ J. Leonard Ivins
J. Leonard Ivins, Chief Executive Officer
Date: August 16, 2010
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.
Signature | Title | Date |
/s/ J. Leonard Ivins | Chief Executive Officer and | August 16, 2010 |
J. Leonard Ivins | Chairman of the Board |